Iodide

Iodide

SCHEMBL3260442

C#Cc1cccc[n+]1C.[I-].c1cc2cc-2c1

nearest known ligand 0.75

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
HDAC8 Q9BY41 6/20 0.75
KCNH2 Q12809 3/20 0.35
KDM4E B2RXH2 2/20 0.34
ALDH1A1 P00352 1/20 0.34
CTDSP1 Q9GZU7 1/20 0.34
APOBEC3A P31941 1/20 0.33
APOBEC3G Q9HC16 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
SLC22A2 O15244 1/20 0.32
SLC22A1 O15245 1/20 0.32
SLC22A3 O75751 1/20 0.32
SLC6A4 P31645 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3528166 0.87
SCHEMBL4067666 0.85 HDAC8 (0.88) HDAC8KCNH2KDM4EAPOBEC3AAPOBEC3G
Iodide SCHEMBL30133746 0.69 HDAC8 (0.95) HDAC8KDM4EALDH1A1CTDSP1APOBEC3A
Propyne SCHEMBL27606886 0.66
SCHEMBL8988114 0.66 HDAC8 (1.00) HDAC8KCNH2KDM4EALDH1A1CTDSP1
SCHEMBL862249 0.66
SCHEMBL4072516 0.66 KCNH2 (0.64) HDAC8KCNH2KDM4EALDH1A1SMN1; SMN2
Hydrochloric Acid SCHEMBL5833068 0.65 HDAC8 (0.95) HDAC8KCNH2KDM4ESMN1; SMN2
Phenylacetylene SCHEMBL28907737 0.63 CYP1A1 (0.41) HDAC8ALDH1A1
SCHEMBL28990980 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7667040-B2 Azacyclic ethynyl derivatives NEUROSEARCH A/S (DK) 2010-02-23 US disclosed
US-20080188519-A1 Novel azacyclic ethynyl derivatives ANIONA APS (DK) 2008-08-07 US disclosed
EP-1506205-B1 NOVEL AZACYCLIC ETHYNYL DERIVATIVES NEUROSEARCH AS (DK) 2008-07-16 EP disclosed
US-7378526-B2 Azacyclic ethynyl derivatives NEUROSEARCH A/S (DK) 2008-05-27 US disclosed
US-20050171078-A1 Novel azacyclic ethynyl derivatives NEUROSEARCH (DK) 2005-08-04 US disclosed
EP-1506205-A2 NOVEL AZACYCLIC ETHYNYL DERIVATIVES NEUROSEARCH A/S (DK) 2005-02-16 EP disclosed
WO-2003094830-A2 NOVEL AZACYCLIC ETHYNYL DERIVATIVES NEUROSEARCH A/S (DK) 2003-11-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050171078-A1 Novel azacyclic ethynyl derivatives CHRNA6, CHRNA5, CHRNA10 HDAC8 1302/4885KCNH2 886/4885KDM4E 1343/4885
US-20080188519-A1 Novel azacyclic ethynyl derivatives CHRNA6, CHRNA10, CHRNA5 HDAC8 1319/4885KCNH2 1154/4885KDM4E 1674/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.